Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immucell (ICCC) Other Non Operating Income (2018 - 2024)

Immucell (ICCC) has disclosed Other Non Operating Income for 6 consecutive years, with -$143679.0 as the latest value for Q2 2024.

  • For the quarter ending Q2 2024, Other Non Operating Income fell 94.97% year-over-year to -$143679.0, compared with a TTM value of -$170865.0 through Jun 2024, up 13.79%, and an annual FY2023 reading of -$21893.0, up 88.3% over the prior year.
  • Other Non Operating Income was -$143679.0 for Q2 2024 at Immucell, down from -$136476.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $827690.0 in Q4 2020 and bottomed at -$333776.0 in Q1 2020.
  • Average Other Non Operating Income over 5 years is -$25980.6, with a median of -$70723.0 recorded in 2020.
  • Peak annual rise in Other Non Operating Income hit 809.67% in 2023, while the deepest fall reached 314.04% in 2023.
  • Year by year, Other Non Operating Income stood at $827690.0 in 2020, then plummeted by 108.48% to -$70156.0 in 2021, then surged by 53.53% to -$32602.0 in 2022, then plummeted by 314.04% to -$134985.0 in 2023, then fell by 6.44% to -$143679.0 in 2024.
  • Business Quant data shows Other Non Operating Income for ICCC at -$143679.0 in Q2 2024, -$136476.0 in Q1 2024, and -$134985.0 in Q4 2023.